Skip to main content
SpringerLink
Log in

RNASEL −1385G/A polymorphism and cancer risk: a meta-analysis based on 21 case–control studies

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Polymorphisms in the endoribonuclease L (RNASEL) gene have been hypothesized to increase the incidence of cancer. The common sequence variation in RNASEL, −1385G/A (rs486907) has been involved in several types of cancer risk. However, results of the related published studies remained conflicting rather than conclusive. To clarify the role of RNASEL −1385G/A genotype in global cancer, we performed a meta-analysis of all the available published studies involving 8,732 cancer patients and 8,748 control subjects. The overall results indicated that there was no major influence of the variant on cancer risk. However, stratified analysis by ethnicity showed that the RNASEL −1385G/A polymorphism has an increased cancer risk in African descendents in the homozygote comparison (OR = 2.59, 95% CI = 1.27–5.27), although no association was found in the analysis stratified by cancer type (OR = 1.12, 95% CI = 0.94–1.35). This meta-analysis suggested that the RNASEL −1385G/A polymorphism is associated with cancer risk in African descendents. To draw more comprehensive conclusions, further prospective studies with larger numbers of participants worldwide are still required to examine associations between RNASEL −1385G/A polymorphism and cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pogo BG, Holland JF (1997) Possibilities of a viral etiology for human breast cancer-a review. Biol Trace Elem Res 56:131–142

    Article  PubMed  CAS  Google Scholar 

  2. Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, Boland CR (1999) JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA 96:7484–7489

    Article  PubMed  CAS  Google Scholar 

  3. Silverman RH (2003) Implications for RNase L in prostate cancer biology. Biochemistry 42:1805–1812

    Article  PubMed  CAS  Google Scholar 

  4. Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH (1993) A dominant negative mutant of 2–5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 12:3297–3304

    PubMed  CAS  Google Scholar 

  5. Lengyel P (1993) Tumour-suppressor genes: news about the interferon connection. Proc Natl Acad Sci USA 90:5893–5895

    Article  PubMed  CAS  Google Scholar 

  6. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Grönberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30:181–184

    Article  PubMed  CAS  Google Scholar 

  7. Wagenlehner FM, Elkahwaji JE, Algaba F, Bjerklund-Johansen T, Naber KG, Hartung R, Weidner W (2007) The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int 100:733–737

    Article  PubMed  CAS  Google Scholar 

  8. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH (1997) Interferon action and apoptosis are defective in mice devoid of 2′, 5′-oligoadenylate-dependent RNase L. EMBO J 16:6355–6363

    Article  PubMed  CAS  Google Scholar 

  9. Zhou A, Hassel BA, Silverman RH (1993) Expression cloning of 2–5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72:753–765

    Article  PubMed  CAS  Google Scholar 

  10. Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, Trent JM, Isaacs WB, Casey G, Silverman RH (2003) Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2′, 5′-oligoadenylates. Cancer Res 63:6795–6801

    PubMed  CAS  Google Scholar 

  11. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS (2002) RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32:581–583

    Article  PubMed  CAS  Google Scholar 

  12. Cybulski C, Wokołorczyk D, Jakubowska A, Gliniewicz B, Sikorski A, Huzarski T, Debniak T, Narod SA, Lubiński J (2007) DNA variation in MSR1, RNASEL and E-Cadherin genes and prostate cancer in Poland. Urol Int 79:44–49

    Article  PubMed  CAS  Google Scholar 

  13. Daugherty SE, Hayes RB, Yeager M, Andriole GL, Chatterjee N, Huang WY, Isaacs WB, Platz EA (2007) RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate 67:849–854

    Article  PubMed  CAS  Google Scholar 

  14. Krüger S, Engel C, Bier A, Silber AS, Görgens H, Mangold E, Pagenstecher C, Holinski-Feder E, von Knebel Doeberitz M, Royer-Pokora B, Dechant S, Pox C, Rahner N, Müller A, Schackert HK, German HNPCC Consortium (2007) The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1. Cancer Lett 252:55–64

    Article  PubMed  Google Scholar 

  15. Nam RK, Zhang WW, Jewett MA, Trachtenberg J, Klotz LH, Emami M, Sugar L, Sweet J, Toi A, Narod SA (2005) The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin Cancer Res 11:8391–8397

    Article  PubMed  CAS  Google Scholar 

  16. Krüger S, Silber AS, Engel C, Görgens H, Mangold E, Pagenstecher C, Holinski-Feder E, von Knebel Doeberitz M, Moeslein G, Dietmaier W, Stemmler S, Friedl W, Rüschoff J, Schackert HK, German Hereditary Non-Polyposis Colorectal Cancer Consortium (2005) Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study. Lancet Oncol 6:566–572

    Article  PubMed  Google Scholar 

  17. Bartsch DK, Fendrich V, Slater EP, Sina-Frey M, Rieder H, Greenhalf W, Chaloupka B, Hahn SA, Neoptolemos JP, Kress R (2005) RNASEL germline variants are associated with pancreatic cancer. Int J Cancer 117:718–722

    Article  PubMed  CAS  Google Scholar 

  18. Beuten J, Gelfond JA, Franke JL, Shook S, Johnson-Pais TL, Thompson IM, Leach RJ (2010) Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. Cancer Epidemiol Biomarkers Prev 19:588–599

    Article  PubMed  CAS  Google Scholar 

  19. Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, Hoffman-Bolton J, Clipp SL, Visvanathan K, Platz EA (2009) Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 20:1739–1751

    Article  PubMed  Google Scholar 

  20. Robbins CM, Hernandez W, Ahaghotu C, Bennett J, Hoke G, Mason T, Pettaway CA, Vijayakumar S, Weinrich S, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD, Kittles RA (2008) Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate 68:1790–1797

    Article  PubMed  Google Scholar 

  21. Wiklund F, Jonsson BA, Brookes AJ, Strömqvist L, Adolfsson J, Emanuelsson M, Adami HO, Augustsson-Bälter K, Grönberg H (2004) Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res 10:7150–7156

    Article  PubMed  CAS  Google Scholar 

  22. Nakazato H, Suzuki K, Matsui H, Ohtake N, Nakata S, Yamanaka H (2003) Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br J Cancer 89:691–696

    Article  PubMed  CAS  Google Scholar 

  23. Rökman A, Ikonen T, Seppälä EH, Nupponen N, Autio V, Mononen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 70:1299–1304

    Article  PubMed  Google Scholar 

  24. Sevinç A, Yannoukakos D, Konstantopoulou I, Manguoglu E, Lüleci G, Colak T, Akyerli C, Colakoglu G, Tez M, Sayek I, Gerassimos V, Nasioulas G, Papadopoulou E, Florentin L, Kontogianni E, Bozkurt B, Kocabas NA, Karakaya AE, Yulug IG, Ozçelik T (2004) Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer. Anticancer Res 24:2547–2549

    PubMed  Google Scholar 

  25. Maier C, Haeusler J, Herkommer K, Vesovic Z, Hoegel J, Vogel W, Paiss T (2005) Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br J Cancer 92:1159–1164

    Article  PubMed  CAS  Google Scholar 

  26. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN (2002) Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 71:116–123

    Article  PubMed  CAS  Google Scholar 

  27. Shea PR, Ishwad CS, Bunker CH, Patrick AL, Kuller LH, Ferrell RE (2008) RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans. Prostate 68:354–359

    Article  PubMed  CAS  Google Scholar 

  28. Shook SJ, Beuten J, Torkko KC, Johnson-Pais TL, Troyer DA, Thompson IM, Leach RJ (2007) Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans. Clin Cancer Res 13:5959–5964

    Article  PubMed  CAS  Google Scholar 

  29. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  30. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    PubMed  CAS  Google Scholar 

  31. Summers K, Crespi B (2008) Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection. Infect Genet Evol 8:297–301

    Article  PubMed  CAS  Google Scholar 

  32. Bisbal C, Silverman RH (2007) Diverse functions of RNase L and implications in pathology. Biochimie 89:789–798

    Article  PubMed  CAS  Google Scholar 

  33. Ioannidis JP (1998) Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 279:281–286

    Article  PubMed  CAS  Google Scholar 

  34. Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4:850–860

    Article  PubMed  CAS  Google Scholar 

  35. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92:1764–1772

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The research was supported by grants from the National Natural Science Foundation of China (No. 30872596).

Author information

Authors and Affiliations

  1. Department of Urology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People’s Republic of China

    Li-Feng Zhang, Yuan-Yuan Mi, Chao Qin, Yong Wang, Qiang Cao, Jun-Feng Wei, Yao-Jun Zhou, Ning-Han Feng & Wei Zhang

Authors
  1. Li-Feng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan-Yuan Mi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chao Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qiang Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun-Feng Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yao-Jun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ning-Han Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Zhang.

Additional information

Li-Feng Zhang, Yuan-Yuan Mi and Chao Qin contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, LF., Mi, YY., Qin, C. et al. RNASEL −1385G/A polymorphism and cancer risk: a meta-analysis based on 21 case–control studies. Mol Biol Rep 38, 5099–5105 (2011). https://doi.org/10.1007/s11033-010-0657-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0657-2

Keywords

Search

Navigation